2,261
Views
8
CrossRef citations to date
0
Altmetric
Review

A systematic review of the burden of pertussis in South Korea

ORCID Icon, &
Pages 1747-1756 | Received 03 Aug 2020, Accepted 25 Oct 2020, Published online: 07 Jan 2021

References

  • CDC. Epidemiology and prevention of vaccine-preventable diseases. Washington D.C., US, Public Health Foundation: National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention; 2015.
  • European Centre for Disease Prevention and Control. Expert consultation on pertussis. Accessed 2020 Jun 10.https://www.ecdc.europa.eu/en/publications-data/expert-consultation-pertussis#:~:text=Pertussis%20is%20a%20highly%20contagious,of%20spread%20to%20young%20children
  • WHO. Pertussis vaccines: WHO position paper – august 2015. Wkly Epidemiol Rec. 2015:35.
  • Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect. 2014;142:672–84. doi:10.1017/S0950268812003093.
  • Libster R, Edwards KM. Re-emergence of pertussis: what are the solutions? Expert Rev Vaccines. 2012;11:1331–46. doi:10.1586/erv.12.118.
  • Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J. 2001;20:63–75. doi:10.1097/00006454-200101000-00013.
  • Rocha G, Soares P, Soares H, Pissarra S, Guimarães H. Pertussis in the newborn: certainties and uncertainties in 2014. Paediatr Respir Rev. 2015;16:112–18. doi:10.1016/j.prrv.2014.01.004.
  • von Koenig CHW, Guiso N. Global burden of pertussis: signs of hope but need for accurate data. Lancet Infect Dis. 2017;17:889–90. doi:10.1016/S1473-3099(17)30357-2.
  • WHO. Pertussis vaccines: WHO position paper, August 2015-Recommendations. Vaccine. 2016;34:1423–25. doi:10.1016/j.vaccine.2015.10.136.
  • Chow MYK, Khandaker G, McIntyre P. Global childhood deaths from pertussis: a historical review. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2016;63:S134–S41. doi:10.1093/cid/ciw529.
  • Thisyakorn U, Tantawichien T, Thisyakorn C, Buchy P. Pertussis in the association of Southeast Asian Nations: epidemiology and challenges. Int J Infect Dis: IJID: Off Publ Int Soc Infect Dis. 2019;87:75–83. doi:10.1016/j.ijid.2019.07.016.
  • Park S, Cho E. National infectious diseases surveillance data of South Korea. Epidemiol Health. 2014;36:e2014030. doi:10.4178/epih/e2014030.
  • Lee J, Choi W. Immunization policy in Korea. Infect Chemother. 2008;40:14–23. doi:10.3947/ic.2008.40.1.14.
  • Choi KM, Kim KH, Kim YJ, Kim JH, Park SE, Lee HJ, Eun BW, Jo DS, Choi EH, Hong YJ, et al. Recommendation for the use of newly introduced Tdap vaccine in Korea. Korean J Pediatr. 2011;54:141–45. doi:10.3345/kjp.2011.54.4.141.
  • KCDC. National immunization program vaccination rate by schedule and area. Accessed 2020 Jul 30. https://nip.cdc.go.kr/irgd/index.html
  • KCDC. The seroepidemiologic study of tetanus and pertussis. Accessed 2020 Apr 07. https://nip.cdc.go.kr/irgd/reference.do?service=getResearchView&strNum=45&GUISEQNUM=112
  • KCDC. Infectious diseases surveillance yearbook, 2017. Accessed 2020 Jul 30. https://is.cdc.go.kr/upload_comm/syview/doc.html?fn=157407476842200.pdf&rs=/upload_comm/docu/0030/
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi:10.1371/journal.pmed.1000097.
  • Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. New Jersey, US: John Wiley & Sons; 2011.
  • Kim SH, Lee J, Sung HY, Yu JY, Kim SH, Park MS, Jung S-O. Recent trends of antigenic variation in Bordetella pertussis isolates in Korea. J Korean Med Sci. 2014;29:328–33. doi:10.3346/jkms.2014.29.3.328.
  • Lee KS, Son JS, Chung EH, Bae HK, Lee MJ, Yu J, Chang YP, Park WS, Kim JK, Rheem I, et al. Prevalence and clinical characteristics of pertussis in children, Cheonan, Korea. Korean J Pediatr Infect Dis. 2009;16:175–82. doi:10.14776/kjpid.2009.16.2.175.
  • Lee SY, Han SB, Bae EY, Kim JH, Kang JH, Park YJ, Ma SH. Pertussis seroprevalence in Korean adolescents and adults using anti-pertussis toxin immunoglobulin G. J Korean Med Sci. 2014;29:652–56. doi:10.3346/jkms.2014.29.5.652.
  • Choe YJ, Park YJ, Jung C, Bae GR, Lee DH. National pertussis surveillance in South Korea 1955-2011: epidemiological and clinical trends. Int J Infect Dis. 2012;16:e850–4. doi:10.1016/j.ijid.2012.07.012.
  • Son S, Thamlikitkul V, Chokephaibulkit K, Perera J, Jayatilleke K, Hsueh PR, Lu C-Y, Balaji V, Moriuchi H, Nakashima Y, et al. Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents. Clin Microbiol Infect. 2019;25:250 e1- e7. doi:10.1016/j.cmi.2018.04.013.
  • Jang JW, Kang JH, Choi JW, Lee HS, Ma SH. Clinical characteristics of pertussis epidemic in Changwon. Pediatr Infect Vaccine. 2017;24:37. doi:10.14776/piv.2017.24.1.37.
  • Park S, Lee SH, Seo KH, Shin KC, Park YB, Lee MG, Yoo KH, Kim HJ, Park JS, Cho JH, et al. Epidemiological aspects of pertussis among adults and adolescents in a Korean outpatient setting: a multicenter, PCR-based study. J Korean Med Sci. 2014;29:1232–39. doi:10.3346/jkms.2014.29.9.1232.
  • Lee SY, Han SB, Kang JH, Kim JS. Pertussis prevalence in Korean adolescents and adults with persistent cough. J Korean Med Sci. 2015;30:988–90. doi:10.3346/jkms.2015.30.7.988.
  • Choe Y, Kim J, Park Y, Jung C, Bae G. Burden of pertussis is underestimated in South Korea: a result from an active sentinel surveillance system. Jpn J Infect Dis. 2014;67:230–32. doi:10.7883/yoken.67.230.
  • Choi WS, Kim SH, Park DW. Seroprevalence of pertussis in healthcare workers without adult pertussis vaccine use at a university hospital in Korea. J Korean Med Sci. 2018;33:e321. doi:10.3346/jkms.2018.33.e321.
  • Han YI, Choi JY, Lee H, Lee T-J. Active surveillance of pertussis in infants under 6 months of age: a single center experience from 2011 to 2013. Korean J Pediatr Infect Dis. 2014;21:114. doi:10.14776/kjpid.2014.21.2.114.
  • Kwon HJ, Yum SK, Choi UY, Lee SY, Kim JH, Kang JH. Infant pertussis and household transmission in Korea. J Korean Med Sci. 2012;27:1547–51. doi:10.3346/jkms.2012.27.12.1547.
  • Lee SY, Choi UY, Kim JS, Ahn JH, Choi JH, Ma SH, Park JS, Kim HM, Kang JH. Immunoassay of pertussis according to ages. Korean J Pediatr Infect Dis. 2012;19:55–60. doi:10.14776/kjpid.2012.19.2.55.
  • Park S, Lee MG, Lee KH, Park YB, Yoo KH, Park JW, Kim C, Lee Yc, Park JS, Kwon YS, Seo Kh, et al. A multicenter study of pertussis infection in adults with coughing in Korea: PCR-based study. Tuberc Respir Dis (Seoul). 2012;73:266–72. doi:10.4046/trd.2012.73.5.266.
  • Park S, Oh KC, Kim KS, Song KT, Yoo KH, Shim YS, Lee YJ, Lee MG, Yun JU, Kim HS, et al. Role of atypical pathogens and the antibiotic prescription pattern in acute bronchitis: a multicenter study in Korea. J Korean Med Sci. 2015;30:1446–52. doi:10.3346/jkms.2015.30.10.1446.
  • Park WB, Park SW, Kim HB, Kim EC, Oh M, Choe KW. Pertussis in adults with persistent cough in South Korea. Eur J Clin Microbiol Infect Dis. 2005;24:156–58. doi:10.1007/s10096-005-1277-y.
  • Ryu S, Kim JJ, Chen MY, Jin H, Lee HK, Chun BC. Outbreak investigation of pertussis in an elementary school: a case-control study among vaccinated students. Clin Exp Vaccine Res. 2018;7:70–75. doi:10.7774/cevr.2018.7.1.70.
  • YooS, AhnKO, ParkEH, ChoHS, ParkCY, Lee HR. Epidemiologic and clinical features of pertussis in children (2000.3–2001.3). J Korean Pediatr Soc. 2002;45(5):603–08.
  • Yook YS, Jeon JS, Park JO, Kim JK. Laboratory investigation of trends in bacterial Pneumonia in Cheonan, Korea, from January 2008 to September 2017. J Microbiol Biotechnol. 2018;28:1730–35. doi:10.4014/jmb.1804.04004.
  • Lee AD, Cassiday PK, Pawloski LC, Tatti KM, Martin MD, Briere EC, Tondella ML, Martin SW. Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT). PloS One. 2018;13:e0195979–e. doi:10.1371/journal.pone.0195979.
  • KCDC. Pertussis Integrated Management Guidelines. Accessed 2020 Jul 30. https://www.cdc.go.kr/board.es?mid=a20507020000&bid=0019&tag=&act=view&list_no=138187
  • Wirsing von König CH. Pertussis diagnostics: overview and impact of immunization. Expert Rev Vaccines. 2014;13:1167–74. doi:10.1586/14760584.2014.950237.
  • Blain A, Skoff T, Cassiday P, Tondella ML, Acosta A. Centers for Disease Control and Prevention. In: Roush SW, Baldy LM, Kirkconnell Hall MA, editors. Manual for the surveillance of vaccine-preventable diseases. chapter 10: pertussis; Atlanta, Georgia, US: Centers for Disease Control and Prevention; 2014.
  • Chung JI, Song YM, Choi JS, Kim BM. Trends in avoidable death over 20 years in Korea. J Korean Med Sci. 2008;23:975–81. doi:10.3346/jkms.2008.23.6.975.
  • Moore A, Harnden A, Grant CC, Patel S, Irwin RS, Altman KW, Azoulay E, Barker AF, Bolser DC, Birring SS, et al. Clinically diagnosing pertussis-associated cough in adults and children: CHEST guideline and expert panel report. CHEST. 2019;155:147–54. doi:10.1016/j.chest.2018.09.027.